OriCiro Genomics is a Japanese bio-innovative therapeutics developer focused on cell-free synthesis and amplification of genomes for advanced therapeutics and synthetic biology. Recently, Moderna announced that it will spend $85 million to acquire OriCiro Genomics, headquartered in Tokyo, Japan.
This article is transferred from: https://www.itjuzi.com/merger/9613
This site is only for collection, and the copyright belongs to the original author.